Endothelial modulation of pulmonary vascular tone

Pulmonary endothelial cells normally synthesize prostacyclin (PGI2) and nitric oxide (NO), which are both potent vasodilators. Although PGI2 is largely used to treat patients with severe pulmonary hypertension, its role in the physiology and pathophysiology of the pulmonary circulation is still debated. NO, which is now considered as the endogenous nitrovasodilator, is perhaps more involved than PGI2 in the mechanisms that modulate pulmonary vascular tone in health and disease. There is evidence to suggest that background release of NO contributes to the normally low pulmonary vascular tone in normoxia. Although there are theoretical grounds to hypothesize that hypoxia reduces the synthesis of NO, lack of the latter does not seem to account for the acute hypoxic pulmonary vasoconstriction. Instead, there is evidence to suggest that NO activity is increased in order to modulate the pulmonary vasopressor response to acute alveolar hypoxia. However, more consistent, concerning the role of NO, are data gathered from studies performed in chronic hypoxic conditions. Both experimental data and studies performed in man demonstrate impairment of NO synthesis and/or release in chronic hypoxic pulmonary hypertension. The impaired NO production, whilst reducing the ability of the pulmonary vasculature to relax, also favours the occurrence of excessive pulmonary vasoconstriction. Lack of NO synthesis might also permit mitogenesis and proliferation of various cell types within the vascular wall. We hypothesize that functional alterations of pulmonary endothelium are likely to affect both reactivity and growth of pulmonary vessels. In this respect, NO probably has a pivotal role in modulating pulmonary vascular tone and controlling pulmonary vascular remodelling in health and disease.

This article has been cited by other articles:

				K. P. Tiev, J. Cabane, F. Aubourg, A. Kettaneh, M. Ziani, L. Mouthon, S. Duong-Quy, I. Fajac, L. Guillevin, and A. T. Dinh-Xuan Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Eur. Respir. J., July 1, 2007; 30(1): 26 - 30. [Abstract] [Full Text] [PDF]

				J. M. Williams and W. J. Pearce Age-dependent modulation of endothelium-dependent vasodilatation by chronic hypoxia in ovine cranial arteries J Appl Physiol, January 1, 2006; 100(1): 225 - 232. [Abstract] [Full Text] [PDF]

				M.M. Hoeper and A.T. Dinh-Xuan Combination therapy for pulmonary arterial hypertension: still more questions than answers Eur. Respir. J., September 1, 2004; 24(3): 339 - 340. [Full Text] [PDF]

				A.T. Dinh-Xuan and R. Naeije The hepatopulmonary syndrome: NO way out? Eur. Respir. J., May 1, 2004; 23(5): 661 - 662. [Full Text] [PDF]

				R. Budhiraja, R. M. Tuder, and P. M. Hassoun Endothelial Dysfunction in Pulmonary Hypertension Circulation, January 20, 2004; 109(2): 159 - 165. [Full Text] [PDF]

				X.L. Huang, D. El Kebir, A.S. De Buys Roessingh, J.C. Schneider, L. Jacob, J.C. Mercier, J. Dall'Ava-Santucci, and A.T. Dinh-Xuan Role of tyrosine phosphatase in the modulation of pulmonary vascular tone Eur. Respir. J., March 1, 2002; 19(3): 525 - 529. [Abstract] [Full Text] [PDF]

				C. D. Fike, S. L. Pfister, M. R. Kaplowitz, and J. A. Madden Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs J Appl Physiol, January 1, 2002; 92(1): 67 - 74. [Abstract] [Full Text] [PDF]

				G. Cella, F. Bellotto, F. Tona, A. Sbarai, G. Mazzaro, G. Motta, and J. Fareed Plasma Markers of Endothelial Dysfunction in Pulmonary Hypertension Chest, October 1, 2001; 120(4): 1226 - 1230. [Abstract] [Full Text] [PDF]

				G. Cella, A. Sbarai, G. Mazzaro, B. Vanzo, S. Romano, D. Hoppensteadt, and J. Fareed Plasma Markers of Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 205 - 208. [Abstract] [PDF]

				C. ADRIE, M. MONCHI, A. TUAN DINH-XUAN, J. DALL'AVA-SANTUCCI, J.-F. DHAINAUT, and M. R. PINSKY Exhaled and Nasal Nitric Oxide as a Marker of Pneumonia in Ventilated Patients Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1143 - 1149. [Abstract] [Full Text]

				E. GABBAY, E. HAYDN WALTERS, B. ORSIDA, H. WHITFORD, C. WARD, T. C. KOTSIMBOS, G. I. SNELL, and T. J. WILLIAMS In Stable Lung Transplant Recipients, Exhaled Nitric Oxide Levels Positively Correlate with Airway Neutrophilia and Bronchial Epithelial iNOS Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2093 - 2099. [Abstract] [Full Text]

				D. Li, N. Zhou, and R. A. Johns Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L841 - L847. [Abstract] [Full Text] [PDF]

				V. I. Peinado, J. A. Barbera, J. Ramirez, F. P. Gomez, J. Roca, L. Jover, J. M. Gimferrer, and R. Rodriguez-Roisin Endothelial dysfunction in pulmonary arteries of patients with mild COPD Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L908 - L913. [Abstract] [Full Text] [PDF]

				S. DEEM, E. R. SWENSON, M. K. ALBERTS, R. G. HEDGES, and M. J. BISHOP Red-Blood-Cell Augmentation of Hypoxic Pulmonary Vasoconstriction . Hematocrit Dependence and the Importance of Nitric Oxide Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1181 - 1186. [Abstract] [Full Text] [PDF]

				J. E. Scarborough, C. W. Daggett, A. J. Lodge, P. J. Chai, J. A. Williamson, J. Jaggers, S. E. George, and R. M. Ungerleider The Role Of Endothelial Nitric Oxide Synthase Expression In The Development Of Pulmonary Hypertension In Chronically Hypoxic Infant Swine J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 343 - 350. [Abstract] [Full Text]

				S. Mehta, D. J. Stewart, D. Langleben, and R. D. Levy Short-term Pulmonary Vasodilation With L-Arginine in Pulmonary Hypertension Circulation, September 15, 1995; 92(6): 1539 - 1545. [Abstract] [Full Text]